Skip to main content
. 2021 Sep 16;16(9):e0251639. doi: 10.1371/journal.pone.0251639

Table 2. Distribution of tumor types in all LFS PV-positive patients (n = 26).

Tumor types diagnosed in PV carriers Number of tumors per PV group (A/B) OR (95% CI), p value Number of patients per group (A/B) % PV carriers per group (A/B) Age at diagnosis (range when >1) in each group (A/B)
Adrenocortical Carcinoma 1 / 13 16.0 (1.5–875.8), 0.009 1 / 13 12.5 / 72.2 44 / 0 to 17
Breast 8 / 4 0.18 (0.03–1.0), 0.03 5 / 3 62.5 / 16.6 21 to 38 / 23 to 57
CNS 2 / 2 0.39 (0.02–6.53), 0.56 2/ 2 25 / 11.1 5 to 11 / 1
Osteosarcoma 3 / NA - 2 / NA 25 / NI 12 to 38 / NA
Thyroid 1 / NA - 1 / NA 12.5 / NI 37 / NA

DBD, pathogenic variants located in the DNA-binding domain; CNS, Central Nervous System tumors; NA, not applicable; NI, not identified.